Tectonic Therapeutic (NASDAQ:TECX) Now Covered by Lifesci Capital
Equities research analysts at Lifesci Capital initiated coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) in a research note issued to investors on Friday,Benzinga reports. The brokerage set an “outperform” rating and a $87.00 price target on the stock. Lifesci Capital’s target price would suggest a potential upside of 277.28% from the […]
